Tenderwize
Wróć do wyszukiwania

Pharmaceutical product with active ingredient Aripiprazole (ATC: N05AX12 - for parenteral administration)

AOK Sachsen - Anhalt·Magdeburg, Germany·Deadline Mar 30, 2027 · 219 days left·Open·Supplies
Structured notice only
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Aripiprazol (ATC: N05AX12 - für die parenterale Applikation)

40/100

Ocena szansy

Needs reviewLow complexity
SuppliesOpen
Skąd ta ocena?

Szansa

40 / 100

Złożoność

15 / 100

Czynniki ryzyka

The buyer may terminate contracts if exclusive contracts for the same active ingredient are later tendered during the c...

No estimated value or minimum volume is provided, making it impossible to assess potential revenue.

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Supplies contract
  • 1 lot
  • Duration 2 YEAR
  • Non-exclusive discount agreements for pharmaceutical products with Aripiprazole (parenteral application) under an open-house model.
  • Any qualified pharmaceutical company can conclude a contract at any time under uniform conditions.
Pokaż pełne podsumowanie

This is a notice for non-exclusive discount agreements (Rabattverträge) under §130a Abs. 8 SGB V for pharmaceutical products containing Aripiprazole (ATC: N05AX12, parenteral application) issued by AOK Sachsen-Anhalt. The procurement follows an 'open-house model' allowing any qualified pharmaceutical company to join at any time during the contract period (01.06.2025 to 31.05.2027). The tender is explicitly not a public procurement under EU law but published for transparency. No estimated value or award criteria are specified; all eligible companies get a contract without competition. The deadline for submission is 31.03.2027, with contracts starting as early as 01.06.2025.

Ryzyka

The buyer may terminate contracts if exclusive contracts for the same active ingredient are later tendered during the c...

No estimated value or minimum volume is provided, making it impossible to assess potential revenue.

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Must be a pharmaceutical company or a group of pharmaceutical companies.

Administrative

  • Must complete and sign the participation documents.
  • Electronic submission allowed only via qualified electronic signature (eIDAS Regulation) to [email protected].

Wymagania mogą być niepełne.

Zamawiający

Lokalizacja

Magdeburg, DEU

Profil zamawiającego

Otwórz profil

Identyfikator

DE258393558

Działalność

Health

Części (1)

LOT-0001

Pharmaceutical product with active ingredient Aripiprazole (ATC: N05AX12 - for parenteral administration)

Non-exclusive discount agreements for finished medicinal products with Aripiprazole (parenteral). The contract is open to all qualifying pharmaceutical companies at any time. No exclusivity; contracts end on 31.05.2027 regardless of start date. The buyer may terminate if exclusive contracts are later tendered.

SuppliesEU fundedElectronic submission

Lokalizacja

DEE03, Germany

Czas trwania

2 YEAR

Kategoria

Pharmaceutical products

Termin

Deadline Mar 30, 2027

Szczegóły zamówienia

Data publikacji
09 Apr 2025
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
232943-2025

Dokumenty (1)

Podobne przetargi